USP Global Seminar Series: Ensuring Quality Hand Sanitizer Production During COVID-19 for Manufacturers

us mfg

Agenda | Event PresentationsUSP Education Videos

Alcohol-based hand sanitizer is an important element in infection prevention, especially during the COVID-19 pandemic. However, when quality is compromised, it can be less effective against infection transmission and can also lead to user harm.

COVID-19-related supply chain pressures have created global shortages that led to new vendors, materials, and production pathways to meet demand. These fast-paced changes have caused an emergence of quality incidents both regionally and globally. Globally, over 200 alcohol-based hand sanitizer quality incidents have been reported in 2020. Specifically, in the United States, approximately 80 alcohol-based hand sanitizer quality incidents were reported in 2020.

On February 23, 2021, USP hosted a Global Seminar, Ensuring Quality Hand Sanitizer Production During COVID-19, to help ensure quality alcohol-based hand sanitizer production and support the safe use of alcohol-based hand sanitizer.

Seminar Topics

Presenters and panelists from USP, U.S. FDA, industry, and public health institutions will discuss the global and regional quality risks and solutions when producing alcohol-based hand sanitizer (including its ingredients such as alcohol), including:

  • Global quality challenges and public health impact of alcohol-based hand sanitizers from import/export regulations to clinical perspectives on the frontline treating consequences from subquality products
  • Regional regulatory and public health strategies to increase trust in alcohol-based hand sanitizers 
  • Standards, current Good Manufacturing Practices (cGMPs), and mitigation strategies for the production (including ingredients such as alcohol), labeling, packaging, storage, transportation, and distribution of alcohol-based hand sanitizer
  • Ingredient verification services to help ensure the quality of the ingredients used in alcohol-based hand sanitizer as well as assist with the qualification of ingredient suppliers
  • Manufacturing perspectives and best practices from industry peers’ sharing insights on quality in action

Presenters and Panelists

U.S. FDA

  • Francis Godwin, M.B.A., Director, Office of Manufacturing Quality
  • Theresa Michele, M.D., Director, Division of Nonprescription Drug Products

Industry & Public Health Institutions

  • Christopher Penzien, Associate Director – Quality Assurance, Perrigo
  • Michael Wisser, Director – CSCA Analytical R&D, Perrigo
  • Daniel E. Brooks, M.D., Medical Director, Banner Poison & Drug Information Center

USP

  • Ronald T. Piervincenzi, Ph.D., Chief Executive Officer
  • Danita Broyles, M.S., Senior Market Development Manager
  • Desmond G. Hunt, Ph.D., Principal Scientific Liaison, Science-General Chapters
  • Catherine Sheehan, DRSc, M.S., M.S., Senior Director, Science-Excipients
  • Misti Spann, Pharm.D., Scientific Liaison, Science, Healthcare Quality & Safety
  • Nurisha Wade, Vice President, Healthcare Quality & Safety

Who should attend?

  • Manufacturers with alcohol-based hand sanitizers as part of their production portfolio 
  • Regulatory agencies who support alcohol-based hand sanitizer manufacturers
  • Other interested industry groups

Executive Summary

Executive Summary

Event Presentations

The approved presentations will be posted upon approval by the presenters.

For further information, please contact Jacqueline D. Starkes.